guangdong taiantang pharma-a
(002433:Shenzhen)
guangdong taiantang pharma-a (002433) Snapshot
|
Open
CNY13.96
|
Previous Close
CNY13.96
|
|
|
Day High
CNY14.05
|
Day Low
CNY13.77
|
|
|
52 Week High
02/20/13 - CNY16.88
|
52 Week Low
06/7/12 - CNY10.25
|
|
|
Market Cap
3.9B
|
Average Volume 10 Days
3.5M
|
|
|
EPS TTM
CNY0.41
|
Shares Outstanding
278.0M
|
|
|
EX-Date
04/2/13
|
P/E TM
34.2x
|
|
|
Dividend
CNY0.03
|
Dividend Yield
0.23%
|
Related News
guangdong taiantang pharma-a (002433) Related Businessweek News
No Related Businessweek News Foundguangdong taiantang pharma-a (002433) Details
Guangdong Taiantang Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and distribution of traditional Chinese medicines primarily in China. It provides ointments, pills, and other products, including medicines for skin and cardiovascular diseases, anti-inflammatory products, and infertility drugs, as well as medicines for women, children, and reproductive health. Guangdong Taiantang Pharmaceutical Co., Ltd. is headquartered in Shanghai, China.
guangdong taiantang pharma-a (002433) Key Developments
Goangdong Taiantang Pharmaceutical Co., Ltd. at its first Extraordinary General Meeting of 2013 held on May 16, 2013, approved amendments to the company's articles of association.
Goangdong Taiantang Pharmaceutical Co., Ltd., Special/Extraordinary Shareholders Meeting, May 16, 2013., at 09:00 China Standard Time. Agenda: To consider the amendments to the company's articles of association; to consider application for credit line and loan to financial institutions; to consider amendments to the company's rules of procedures governing shareholders' general meetings; to consider amendments to the company's rules of procedures governing the board meetings; to consider amendments to work rules for independent directors; to consider the absorption and merger of a wholly-owned subsidiary; and to consider the election of directors, independent director and supervisor.
Goangdong Taiantang Pharmaceutical Co., Ltd. at its first Extraordinary General Meeting of 2013 to be held on May 16, 2013, is to consider the amendments to the company's articles of association.
| Recently Viewed | |||
| 002433:CH | CNY13.97 CNY | +0.01 |  |
| Company | Last | Change | |
| No competitor information is available for 002433. | |||
| View Industry Companies | |||
Industry Analysis
002433
Industry Average
| Valuation | 002433 | Industry Range |
| Price/Earnings | 28.6x |
|
| Price/Sales | 3.8x |
|
| Price/Book | 1.1x |
|
| Price/Cash Flow | 42.7x |
|
| TEV/Sales | 6.0x |
|
Post a JobJobs
- Orlando, FL | Consult SoftPosted: May 22
- New York, NY |Posted: May 17
- San Francisco, CA | YelpPosted: May 02
- San Francisco, CA | YelpPosted: May 02
Sponsored Financial Commentaries
Sponsored Links
To contact GUANGDONG TAIANTANG PHARMA-A, please visit www.pibao.cn. Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.
